Cellular proliferation in pilocytic and diffuse astrocytomas

Area of Science:

• Neuro-oncology
• Pathology
• Cancer Biomarkers

Background:

• Astrocytomas are primary brain tumors with varying prognoses.
• Accurate prognostic markers are crucial for guiding treatment and predicting patient outcomes.
• The MIB-1 labeling index (LI), a measure of cell proliferation, is increasingly used in tumor assessment.

Purpose of the Study:

• To evaluate the MIB-1 labeling index (LI) in pilocytic and diffuse astrocytomas.
• To determine the prognostic significance of MIB-1 LI for survival in astrocytoma patients.
• To compare MIB-1 LI with established prognostic factors like tumor grade and histologic features.

Main Methods:

• Quantitative image analysis was used to assess MIB-1 LI in 131 pilocytic and 140 diffuse astrocytomas.
• Diffuse astrocytomas were classified into grades 2, 3, and 4 using the St. Anne-Mayo scheme.
• MIB-1 LI was correlated with survival and other histologic parameters (atypia, mitoses, endothelial proliferation, necrosis).

Main Results:

• MIB-1 LI was significantly higher in diffuse astrocytomas compared to pilocytic astrocytomas and increased with higher grades.
• In diffuse astrocytomas, MIB-1 LI strongly correlated with tumor grade, mitotic activity, and patient survival.
• Necrosis was the strongest predictor of survival in all diffuse astrocytoma grades; however, MIB-1 LI was the sole independent predictor in grades 2 and 3 on multivariate analysis.

Conclusions:

• MIB-1 LI is a valuable prognostic marker for diffuse astrocytomas, particularly in grades 2 and 3.
• The findings suggest that the current cutoff points in the St. Anne-Mayo grading scheme for diffuse astrocytomas may require revision.
• Further investigation into the optimal grading of diffuse astrocytomas based on proliferation markers like MIB-1 LI is warranted.